Goldman Sachs Resumes Coverage of Immunovant (IMVT) with a Hold Rating

16 7 月, 2025

One Min Read

8 Views

原文: https://finance.yahoo.com/news/goldman-sachs-resumes-coverage-immunovant-133847504.html

Last Update: 16 7 月, 2025

Written By

Other Articles

Previous

Crinetics Pharmaceuticals (CRNX) Gets Initiated With a Hold Rating at Goldman Sachs

Next

BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept